Fiza Singh

Title(s)Associate Professor Of Clinical, Psychiatry
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Focused Review of Gamma Neuromodulation as a Therapeutic Target in Alzheimer's Spectrum Disorders. J Psychiatr Brain Sci. 2024; 9(1). Shu IW, Lin Y, Granholm EL, Singh F. PMID: 38550308; PMCID: PMC10976397.
      View in: PubMed   Mentions:
    2. Targeting Frontal Gamma Activity with Neurofeedback to Improve Working Memory in Schizophrenia. Curr Top Behav Neurosci. 2023; 63:153-172. Shu IW, Granholm EL, Singh F. PMID: 35989397.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    3. Corrigendum to 'Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD)' [Psychiatry Research 238 (2016) 374-377]. Psychiatry Res. 2021 Dec; 306:114177. Minichino A, Singh F, Pineda J, Friederich E, Cadenhead KS. PMID: 34624704.
      View in: PubMed   Mentions:    Fields:    
    4. Modulation of frontal gamma oscillations improves working memory in schizophrenia. Neuroimage Clin. 2020; 27:102339. Singh F, Shu IW, Hsu SH, Link P, Pineda JA, Granholm E. PMID: 32712452; PMCID: PMC7390812.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    5. Revisiting the Potential of EEG Neurofeedback for Patients With Schizophrenia. Schizophr Bull. 2020 07 08; 46(4):741-742. Singh F, Shu IW, Granholm E, Pineda JA. PMID: 32133510; PMCID: PMC7345762.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. A Systematic Review of the Potential Use of Neurofeedback in Patients With Schizophrenia. Schizophr Bull Open. 2020 Jan; 1(1):sgaa005. Gandara V, Pineda JA, Shu IW, Singh F. PMID: 32803157; PMCID: PMC7418870.
      View in: PubMed   Mentions: 11  
    7. Assessing the Effectiveness of Neurofeedback Training in the Context of Clinical and Social Neuroscience. Brain Sci. 2017 Aug 07; 7(8). Orndorff-Plunkett F, Singh F, Aragón OR, Pineda JA. PMID: 28783134; PMCID: PMC5575615.
      View in: PubMed   Mentions: 10  
    8. Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD). Psychiatry Res. 2016 Apr 30; 238:374-377. Minichino A, Singh F, Pineda J, Friederich E, Cadenhead KS. PMID: 26970656.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    9. Effects of intranasal oxytocin on neural processing within a socially relevant neural circuit. Eur Neuropsychopharmacol. 2016 Mar; 26(3):626-30. Singh F, Nunag J, Muldoon G, Cadenhead KS, Pineda JA, Feifel D. PMID: 26727038.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Biomarkers in psychosis: an approach to early identification and individualized treatment. Biomark Med. 2014; 8(1):51-7. Mirzakhanian H, Singh F, Cadenhead KS. PMID: 24325224; PMCID: PMC6984197.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Developing Research Domain Criteria (RDoC) to improve diagnosis and treatment of social deficits in psychiatric disorders: the Mirror Neuron System as a model. Schizophr Res. 2013 Dec; 151(1-3):293-4. Singh F, Feifel D. PMID: 24094678.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum. Cogn Neuropsychiatry. 2013; 18(1-2):26-43. Mirzakhanian H, Singh F, Seeber K, Shafer KM, Cadenhead KS. PMID: 22994363; PMCID: PMC3719179.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Ethical implications for clinical practice and future research in "at risk" individuals. Curr Pharm Des. 2012; 18(4):606-12. Singh F, Mirzakhanian H, Fusar-Poli P, de la Fuente-Sandoval C, Cadenhead KS. PMID: 22239594; PMCID: PMC6984196.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Association of impaired EEG mu wave suppression, negative symptoms and social functioning in biological motion processing in first episode of psychosis. Schizophr Res. 2011 Aug; 130(1-3):182-6. Singh F, Pineda J, Cadenhead KS. PMID: 21549567; PMCID: PMC3139731.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    Fiza's Networks
    Concepts (58)
    Derived automatically from this person's publications.
    Co-Authors (5)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department